EUVIMEDEUVIMED entdecken
Crossref

Atomoxetine attenuates methotrexate-induced lung injury in rats implicating TLR4/NF-κB and Bax/Bcl-2/caspase-3 signaling cascades: a study based on molecular docking and experimental validation

Reham H Mohyeldin, Ehab E Sharata, Ayman M Ibrahim, Mina Ezzat Attya, Al Shaimaa Mahmoud Kotb, Remon Roshdy Rofaeil, Yassmen Mohamed Montaser A Khalifa, Mahmoud Abdelnaser

Naunyn-Schmiedeberg's Archives of Pharmacology · 2026-07 · 399 (10) · 15609-15627

DOI: 10.1007/s00210-026-05345-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Naunyn-Schmiedeberg's Archives of Pharmacology, online erschienen am 30.04.2026. Verfasst von Reham H Mohyeldin und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology & Toxicology, Faculty of Pharmacy, Deraya University, 61111, Minia, Egypt. Hauptthemen laut MEDLINE: Methotrexate, Atomoxetine Hydrochloride, Lung Injury. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 79 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Methotrexate (MTX) is frequently used to treat a variety of autoimmune diseases and malignancies, but its use is restricted due to a number of side effects, including lung damage. For the first time, this study attempts to assess the potential protective advantages of atomoxetine (ATOM) against MTX-induced lung damage in rats. MTX was used to cause lung damage. A total of 24 male Wistar albino rats were used in this study. Animals were randomly allocated to four experimental groups of six rats each: (Ⅰ) Control group, (Ⅱ) ATOM group, (Ⅲ) MTX group, and (Ⅳ) MTX+ATOM group. Malondialdehyde (MDA), glutathione (GSH), and superoxide dismutase (SOD) levels in the lungs were measured. ELISA was used to measure the levels of lung IL-10, interleukin-6 (IL-6), tumor necrosis factor-α (TNF-α), Bcl-2-associated X protein (Bax), and B-cell lymphoma 2 (Bcl-2). NF-κB p65 and caspase-3 were evaluated using immunohistochemistry. Toll-like receptor 4 (TLR4) and myeloid differentiation primary response 88 (MYD88) protein expression levels were assessed using the Western blot technique. A histopathological study of lung tissues was performed. Lung MDA, IL-6, TNF-α, and Bax levels were significantly increased by MTX, while GSH, SOD, IL-10, and Bcl-2 levels were significantly decreased. Additionally, this led to the overexpression of the proteins TLR4 and MYD88. Additionally, the MTX group had higher immunopositivity for both NF-κB p65 and caspase-3. All of the aforementioned biochemical and histological abnormalities were greatly improved with ATOM. ATOM significantly improved MTX-induced pulmonary injury by suppressing TLR4/MYD88/NF-κB p65 and caspase-3-mediated apoptotic signaling pathways.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MethotrexateAtomoxetine HydrochlorideLung InjuryAnimalsToll-Like Receptor 4MaleCaspase 3bcl-2-Associated X ProteinProto-Oncogene Proteins c-bcl-2Rats, WistarSignal TransductionNF-kappa BMolecular Docking SimulationLungRatsApoptosis

Stichwörter der Autor:innen

AtomoxetineCaspase-3Lung injuryMethotrexateNF-κBTLR4

Substanzen

Toll-Like Receptor 4MethotrexateCaspase 3Tlr4 protein, ratbcl-2-Associated X ProteinProto-Oncogene Proteins c-bcl-2NF-kappa BAtomoxetine HydrochlorideBax protein, ratCasp3 protein, rat

Autor:innen und Institutionen

  • Department of Pharmacology & Toxicology, Faculty of Pharmacy, Deraya University, 61111, Minia, Egypt.
  • Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Deraya University, 61111, Minia, Egypt.
  • Department of Pathology, Faculty of Medicine, Minia University, Minia, 61519, Egypt.
  • Department of Pathology, Faculty of Medicine, Minia National University, Minia, 61519, Egypt.
  • Department of Biochemistry, Molecular Biology and Physiology, Faculty of Medicine, Mutah University, Al‑Karak, Jordan.
  • Medical Physiology Department, Faculty of Medicine, Minia University, Minia, 61519, Egypt.

Zitieren

APA

Mohyeldin, R. H., Sharata, E. E., Ibrahim, A. M., Attya, M. E., Kotb, A. S. M., Rofaeil, R. R., Khalifa, Y. M. M. A., & Abdelnaser, M. (2026). Atomoxetine attenuates methotrexate-induced lung injury in rats implicating TLR4/NF-κB and Bax/Bcl-2/caspase-3 signaling cascades: a study based on molecular docking and experimental validation. Naunyn-Schmiedeberg's Archives of Pharmacology, 399(10), 15609-15627. https://doi.org/10.1007/s00210-026-05345-2

Vancouver

Mohyeldin RH, Sharata EE, Ibrahim AM, Attya ME, Kotb ASM, Rofaeil RR, et al. Atomoxetine attenuates methotrexate-induced lung injury in rats implicating TLR4/NF-κB and Bax/Bcl-2/caspase-3 signaling cascades: a study based on molecular docking and experimental validation. Naunyn-Schmiedeberg's Archives of Pharmacology. 2026;399(10):15609-15627. doi:10.1007/s00210-026-05345-2

BibTeX
@article{Mohyeldin2026,
  author = {Mohyeldin, Reham H and Sharata, Ehab E and Ibrahim, Ayman M and Attya, Mina Ezzat and Kotb, Al Shaimaa Mahmoud and Rofaeil, Remon Roshdy and Khalifa, Yassmen Mohamed Montaser A and Abdelnaser, Mahmoud},
  title = {Atomoxetine attenuates methotrexate-induced lung injury in rats implicating TLR4/NF-κB and Bax/Bcl-2/caspase-3 signaling cascades: a study based on molecular docking and experimental validation},
  journal = {Naunyn-Schmiedeberg's Archives of Pharmacology},
  year = {2026},
  volume = {399},
  number = {10},
  pages = {15609--15627},
  doi = {10.1007/s00210-026-05345-2}
}
Kostenlos starten →